Schedule 13G ownership disclosure

ARIDIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 040334104

Event date: 2023-03-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-23-000878
Form type
SC 13G
Filer
Aridis Pharmaceuticals, Inc.
CIK
CIK 1614067
Filed
Mar 20, 2023
Reporting period
Mar 16, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub